Covishield is the Oxford University - AstraZeneca's candidate in the Covid-19 vaccine race.
However, following the halt, there has been a lot of confusion regarding the countries that have temporarily discontinued the vaccine trials.
Separately, he pointed out that local biotech company SK Bioscience has already signed contract manufacturing organization deals with foreign manufacturers to make coronavirus vaccine candidate materials in the country that should help meet local needs.
Poonawalla said the world will need about 15 billion doses, if the coronavirus vaccine program would require two doses, like the one for measles. But, I haven't heard of anyone approaching even close to this level now, he told the FT.
Poonawalla's remarks came a day after Union health minister Harsh Vardhan said a vaccine against the coronavirus disease would be ready by early next year.
Vaxart's COVID-19 vaccine is using the same platform technology as its more advanced influenza vaccine program, which released topline data from a Phase 2 challenge study earlier this year.
Oxford University, where the vaccine was developed, said in a separate statement that the nature of the illness can not be revealed "for reasons of participant confidentiality". According to the agreement with Novavax, the vaccine targets 92 countries/regions.
AstraZeneca issued a statement on Tuesday night saying the late-stage studies of the vaccine had been paused while the company investigated whether a patient's reported side effects were connected to the vaccine.
Pune-based SII has partnered with five worldwide pharmaceutical companies, including AAstraZeneca and Novavax, to develop a vaccine for the virus.
While every country is trying to develop a successful corona vaccine, Russian Federation and China are the first two countries that are already providing the Covid vaccine to its people before completing trials.
Karliczek said Germany wouldn't cut corners when it comes to testing vaccines, meaning most of the population may have to wait until mid-2021 to be inoculated.
Phase III clinical trials of Russia's Sputnik V vaccine against COVID-19 will be conducted in the Brazilian states of Bahia and Parana, which has plans to produce the vaccine for Brazil and other Latin American countries. Will we have a Vaccine before the Election?